BioNTech seeks approval for COVID vaccine for kids under 12
September 10, 2021
Studies show lower vaccine dose safe, effective for children aged 5 to 11, says German pharma company
BioNTech is set to apply for approval for its COVID-19 vaccine for children younger than 12, the company announced on Friday.
“We will present the result...